Frédéric Lézot

59 papers receiving 2.0k citations

Peers

Frédéric Lézot
Comparison fields: 5 of 103
  • Rheumatology 508
  • Oral Surgery 229
  • Cancer Research 344
  • Oncology 606
  • Molecular Biology 1.2k
Replace Kei Sakamoto with:
Kei Sakamoto Japan
Sarah E. Funk United States
Yuki Matsushita Japan
Mengrui Wu China
Shintaro Kawano Japan
Wanida Ono United States
Jérôme Amiaud France
Carolina A. Yoshida Japan
Coralee E. Tye United States
Michael T. Engsig Denmark
Frédéric Lézot relative to Kei Sakamoto Japan Kei Sakamoto's profile →
Citations per field
00.5×1.5×2.1×
Kei Sakamoto · 1×
Citations per year

Countries citing papers authored by Frédéric Lézot

Since Specialization
Citations

This map shows the geographic impact of Frédéric Lézot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lézot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lézot more than expected).

Fields of papers citing papers by Frédéric Lézot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Lézot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lézot. The network helps show where Frédéric Lézot may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Lézot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Lézot Line = papers co-authored together Frédéric Lézot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2017171
2 2014131
3 2016124
4 2018123
5 2001102
6 2020100
7 202372
8 200766
9 201456
10 201152
11 200851
12 200550
13 201850
14 199646
15 200244
16 201043
17 201742
18 201142
19 200042
20 201840

About Frédéric Lézot

Frédéric Lézot is a scholar working on Rheumatology, Oral Surgery, Oncology, Cancer Research and Molecular Biology, having authored 59 papers that have together received 2.0k indexed citations. Recurring topics across this work include dental development and anomalies (25 papers), Bone and Dental Protein Studies (20 papers), Bone health and treatments (19 papers), Bone Metabolism and Diseases (19 papers), Oral and Maxillofacial Pathology (9 papers), NF-κB Signaling Pathways (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Vitamin D Research Studies (4 papers). The work is most often cited by research in Rheumatology (508 citations), Oral Surgery (229 citations), Cancer Research (344 citations), Oncology (606 citations) and Molecular Biology (1.2k citations). Frédéric Lézot has collaborated with scholars based in France, United Kingdom and Colombia. Frequent co-authors include Dominique Heymann, Ariane Berdal, Marie‐Françoise Heymann, Dominique Hotton, Beatriz Castañeda, Françoise Rédiní, Hideo Yagita∥, B. Robert, Christopher G. Mueller and Denis Cochonneau. Their work appears in journals such as Bone, Journal of Cellular Physiology, Biochemical Pharmacology, Cancers and Connective Tissue Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026